View Older Stories View More Recent Stories
-
Aeglea BioTherapeutics (AGLE) Prices 4.5M Share Common Offering at $8/Sh
-
Cathay General Bancorp (CATY) PT Lowered to $48 at BMO Capital
-
Alcoa (AA) PT Raised to $80 at BMO Capital
-
GrafTech Announces the Pricing of Its Initial Public Offering
-
Aeglea BioTherapeutics Prices Public Offering of Common Stock
-
Aeglea BioTherapeutics Prices Public Offering of Common Stock
-
Rigel Pharma (RIGL) Announces Proposed 15M Share Common Offering
-
Rigel Announces Proposed Public Offering Of Common Stock
-
Comerica (CMA) PT Lowered to $109 at BMO Capital; 'Weaker PPNR Partly Offset by Lower LLP'
-
CSX (CSX) PT Raised to $65 at BMO Capital
-
Celanese (CE) PT Raised to $137 at BMO Capital
-
Rigel Pharmaceuticals (RIGL) PT Raised to $8 at BMO Capital on FDA Approval
-
Aeglea BioTherapeutics (AGLE) Announces 4.5M Share Common Offering
-
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
-
Aeglea BioTherapeutics Announces Proposed Public Offering of Common Stock
-
Goldman Sachs (GS) PT Raised to $245 at BMO Capital, 'Happy Days Are here Again'
-
Bristol-Myers Squibb Co. (BMY) PT Lowered to $47 at BMO Capital; 'More Headwinds and Uncertainty Ahead'
-
Extendicare Completes $110 million Offering of 5.00% Convertible Debentures
-
Extendicare Completes $110 million Offering of 5.00% Convertible Debentures
-
BMO Capital Downgrades Vermilion Energy (VET) to Market Perform
-
Netflix (NFLX) PT Raised to $324 at BMO Capital; 'Another Beat Supports Strong Sentiment'
-
J.B. Hunt Transport Services (JBHT) PT Raised to $127 at BMO Capital
-
Trilogy Metals Announces US$25 Million Bought Deal Offering of Common Shares
-
Facebook (FB) PT Lowered to $170 at BMO Capital
-
Impax Laboratories (IPXL) PT Raised to $20 at BMO Capital, ''Amneal Paints Bright Picture'
-
Victoria Gold Announces Execution of Definitive Documentation for the Eagle Financing Package and Closing of Equity and Royalty (First Tranche)
-
BMO Capital Upgrades Golden Star Resources (GSS) to Outperform
-
UPDATE: BMO Capital Upgrades Nielsen Holdings (NLSN) to Outperform
-
Alliance Data Systems (ADS) PT Lowered to $230 at BMO Capital
-
Acxiom (ACXM) PT Lowered to $33 at BMO Capital
-
JPMorgan (JPM) PT Lowered to $110 at BMO Capital
-
Wells Fargo (WFC) PT Lowered to $57 at BMO Capital
-
Citi (C) PT Raised to $76 at BMO Capital
-
PNC Financial (PNC) PT Lowered to $168 at BMO Capital; 'Beat on LLP, but Revenue Missed'
-
CCL Industries Inc. Announces Closing of $300 Million Offering of 3.864% Notes due 2028
-
UPDATE: BMO Capital Upgrades Eli Lilly (LLY) to Market Perform Citing More Balanced Risk/Reward
-
Kansas City Southern (KSU) PT Raised to $120 at BMO Capital
-
Warrior Met Coal (HCC) PT Lowered to $32 at BMO Capital
-
BMO Capital Upgrades FMC Corp. (FMC) to Outperform
-
CCL Industries Inc. Announces $300 Million Offering of 3.864% Notes due 2028
-
U.S. consumer prices drop, but core inflation firming
-
MSC Industrial (MSM) PT Raised to $104 at BMO Capital
-
EXFO Inc. (EXFO) PT Lowered to $4.75 at BMO Capital
-
TCR2 Therapeutics Appoints Leading Biotech Analyst Ian Somaiya as Chief Financial Officer
-
Clearpool Group and BMO Capital Markets Announce Strategic Technology Partnership
-
BMO Capital Markets to Enhance Algorithmic Trading Technology Through Partnership With Clearpool Group
-
BMO Capital Upgrades Keane Group (FRAC) to Outperform Citing Upcoming Improvement to Fundamentals
-
BMO Capital Downgrades Kinross Gold (KGC) to Market Perform
-
BMO Capital Downgrades Monsanto (MON) to Market Perform
-
Merck's Keytruda helps lung cancer patients live longer in trial

